TLP
Tri Locum Partners Portfolio holdings
AUM
$330M
This Quarter Return
+29.51%
1 Year Return
+35.44%
3 Year Return
+388.28%
5 Year Return
–
10 Year Return
–
AUM
$275M
AUM Growth
–
Cap. Flow
+$275M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
61.92%
Holding
65
New
65
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$25.6M |
| 2 |
Baxter International
BAX
|
$24M |
| 3 |
Medtronic
MDT
|
$23.9M |
| 4 |
AbbVie
ABBV
|
$20.7M |
| 5 |
Viatris
VTRS
|
$19.6M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 92.78% |
| 2 | Consumer Staples | 1.61% |
| 3 | Communication Services | 0.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Johnson & Johnson
JNJ
$427B
| $25.6M | 9.3% | +162,633 | New | +$25.6M |
|
|
2
Baxter International
BAX
$12.7B
| $24M | 8.7% | +298,721 | New | +$24M |
|
|
3
Medtronic
MDT
$119B
| $23.9M | 8.68% | +204,138 | New | +$23.9M |
|
|
4
AbbVie
ABBV
$372B
| $20.7M | 7.52% | +193,223 | New | +$20.7M |
|
|
5
Viatris
VTRS
$12.3B
| $19.6M | 7.12% | +1,046,794 | New | +$19.6M |
|
|
WBA
6
DELISTED
Walgreens Boots Alliance
WBA
| $17.6M | 6.39% | +441,324 | New | +$17.6M |
|
7
Labcorp
LH
$23.1B
| $11M | 4% | +54,105 | New | +$11M |
|
|
CCXI
8
DELISTED
ChemoCentryx, Inc.
CCXI
| $10.3M | 3.73% | +166,077 | New | +$10.3M |
|
9
Eli Lilly
LLY
$657B
| $9.37M | 3.4% | +55,521 | New | +$9.37M |
|
10
Zai Lab
ZLAB
$3.68B
| $8.42M | 3.06% | +62,235 | New | +$8.42M |
|
|
BPMC
11
DELISTED
Blueprint Medicines
BPMC
| $8.29M | 3.01% | +73,906 | New | +$8.29M |
|
12
Elevance Health
ELV
$71.8B
| $7.51M | 2.73% | +23,374 | New | +$7.51M |
|
13
Mersana Therapeutics
MRSN
$36.5M
| $7.24M | 2.63% | +271,974 | New | +$7.24M |
|
14
Apellis Pharmaceuticals
APLS
$3.48B
| $6.95M | 2.52% | +121,409 | New | +$6.95M |
|
15
Incyte
INCY
$16.5B
| $5.86M | 2.13% | +67,384 | New | +$5.86M |
|
16
Protagonist Therapeutics
PTGX
$3.67B
| $5.23M | 1.9% | +259,283 | New | +$5.23M |
|
17
Regeneron Pharmaceuticals
REGN
$61.5B
| $5.04M | 1.83% | +10,423 | New | +$5.04M |
|
|
GWPH
18
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $4.64M | 1.68% | +40,159 | New | +$4.64M |
|
|
TRIL
19
DELISTED
Trillium Therapeutics Inc.
TRIL
| $4.37M | 1.59% | +296,838 | New | +$4.37M |
|
20
Arrowhead Research
ARWR
$3.05B
| $4.3M | 1.56% | +56,003 | New | +$4.3M |
|
21
TG Therapeutics
TGTX
$4.65B
| $3.64M | 1.32% | +69,932 | New | +$3.64M |
|
22
ALX Oncology
ALXO
$62.7M
| $3.38M | 1.23% | +39,226 | New | +$3.38M |
|
|
AXNX
23
DELISTED
Axonics, Inc. Common Stock
AXNX
| $3.21M | 1.17% | +64,378 | New | +$3.21M |
|
|
SNCE
24
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| $3.2M | 1.16% | +300,000 | New | +$3.2M |
|
25
Intellia Therapeutics
NTLA
$1.22B
| $3.07M | 1.11% | +56,402 | New | +$3.07M |
|